Gujarat Themis Biosyn Ltd. | Small-cap | Healthcare
₹381.80
5.19%
| Gujarat Themis Stock Comparison:
Gujarat Themis vs Sun PharmaceuticalGujarat Themis vs Divi's LaboratoriesGujarat Themis vs Sun Pharma AdvancedGujarat Themis vs Aarti DrugsGujarat Themis vs Sequent ScientificGujarat Themis vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 377.4M
Gross Profit 293.9M 77.87%
Operating Income 148.1M 39.25%
Net Income 120.0M 31.79%

Balance Sheet Metrics

Total Assets 3.0B
Total Liabilities 529.3M
Shareholders Equity 2.5B
Debt to Equity 0.21

Cash Flow Metrics

Revenue & Profitability Trend

Gujarat Themis Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.5B1.7B1.5B1.1B904.2M
Cost of Goods Sold i318.8M416.1M307.8M208.9M211.1M
Gross Profit i1.2B1.3B1.2B933.0M693.2M
Gross Margin % i78.9%75.5%79.2%81.7%76.7%
Operating Expenses
Research & Development i-38.9M29.3M4.5M0
Selling, General & Administrative i-17.6M24.5M11.2M8.5M
Other Operating Expenses i374.4M333.4M297.0M263.4M199.2M
Total Operating Expenses i374.4M389.8M350.8M279.1M207.8M
Operating Income i634.7M755.3M725.1M565.7M395.5M
Operating Margin % i42.1%44.5%49.0%49.5%43.7%
Non-Operating Items
Interest Income i-40.4M51.3M32.6M21.5M
Interest Expense i3.6M1.4M948.0K7.3M7.9M
Other Non-Operating Income-----
Pre-tax Income i655.4M793.3M774.6M590.3M408.8M
Income Tax i167.7M201.7M195.0M154.1M107.0M
Effective Tax Rate % i25.6%25.4%25.2%26.1%26.2%
Net Income i487.7M591.6M579.7M436.2M301.8M
Net Margin % i32.3%34.8%39.1%38.2%33.4%
Key Metrics
EBITDA i715.5M835.4M801.4M620.5M434.0M
EPS (Basic) i₹4.48₹5.43₹5.32₹4.00₹2.77
EPS (Diluted) i₹4.48₹5.43₹5.32₹4.00₹2.77
Basic Shares Outstanding i108865402108965265108965265108965265108965265
Diluted Shares Outstanding i108865402108965265108965265108965265108965265

Income Statement Trend

Gujarat Themis Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i116.9M64.7M60.5M2.6M39.7M
Short-term Investments i18.5M81.1M28.5M216.1M362.3M
Accounts Receivable i312.4M270.3M179.1M251.2M147.1M
Inventory i50.5M33.3M146.2M116.1M60.5M
Other Current Assets21.4M8.7M1.0K4.0K2.9M
Total Current Assets i519.7M475.6M617.3M783.9M633.2M
Non-Current Assets
Property, Plant & Equipment i411.3M14.7M22.6M22.6M22.6M
Goodwill i1.6M----
Intangible Assets i1.6M----
Long-term Investments-----
Other Non-Current Assets212.7M9.1M1.0M1.2M6.4M
Total Non-Current Assets i2.5B1.7B1.0B441.1M249.4M
Total Assets i3.0B2.2B1.7B1.2B882.6M
Liabilities
Current Liabilities
Accounts Payable i146.5M99.1M95.4M66.2M35.4M
Short-term Debt i8.3M15.4M4.2M7.5M38.3M
Current Portion of Long-term Debt-----
Other Current Liabilities5.1M10.6M15.2M25.5M7.5M
Total Current Liabilities i205.6M161.6M152.8M171.6M158.2M
Non-Current Liabilities
Long-term Debt i296.4M12.2M04.2M10.0M
Deferred Tax Liabilities i19.6M16.6M13.0M10.2M9.8M
Other Non-Current Liabilities--1.0K-1.0K-2.0K-1.0K
Total Non-Current Liabilities i323.7M35.8M19.0M20.2M24.9M
Total Liabilities i529.3M197.4M171.8M191.8M183.2M
Equity
Common Stock i109.0M72.6M72.6M72.6M72.6M
Retained Earnings i-1.9B1.4B937.4M603.6M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i2.5B2.0B1.5B1.0B699.5M
Key Metrics
Total Debt i304.7M27.7M4.2M11.7M48.3M
Working Capital i314.1M314.0M464.5M612.3M475.0M

Balance Sheet Composition

Gujarat Themis Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i655.4M793.3M774.6M590.3M408.8M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i319.6M37.0M-181.0M-75.9M-161.8M
Operating Cash Flow i969.9M795.1M543.8M491.4M227.3M
Investing Activities
Capital Expenditures i-1.2B-746.4M-237.0M-139.0M-30.5M
Acquisitions i-----
Investment Purchases i-----
Investment Sales i---050.0K
Investing Cash Flow i-1.2B-746.4M-237.0M-139.0M-30.4M
Financing Activities
Share Repurchases i-----
Dividends Paid i-18.2M-69.0M-124.4M-100.0M-24.0M
Debt Issuance i298.9M---0
Debt Repayment i--0-30.7M-20.1M
Financing Cash Flow i280.7M-69.0M-124.4M-130.7M-44.1M
Free Cash Flow i-251.2M-104.3M157.7M264.2M74.7M
Net Change in Cash i89.2M-20.4M182.5M221.7M152.8M

Cash Flow Trend

Gujarat Themis Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 88.96
Price to Book 15.92
Price to Sales 26.80
PEG Ratio -2.82

Profitability Ratios

Profit Margin 30.17%
Operating Margin 33.14%
Return on Equity 19.64%
Return on Assets 16.19%

Financial Health

Current Ratio 2.53
Debt to Equity 12.27
Beta -0.40

Per Share Data

EPS (TTM) ₹4.08
Book Value per Share ₹22.80
Revenue per Share ₹13.59

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
gujthem39.6B88.9615.9219.64%30.17%12.27
Sun Pharmaceutical 3.9T37.885.4515.08%19.29%3.26
Divi's Laboratories 1.6T70.7910.9314.64%23.89%0.03
Sun Pharma Advanced 47.8B-13.92-21.95157.88%-53.22%-1.24
Aarti Drugs 44.8B23.753.2812.28%7.80%44.92
Sequent Scientific 44.3B153.956.282.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.